Hong Kong IPO de­liv­ers $421M to In­novent as an­oth­er one of Chi­na's biotech uni­corns hauls in big mon­ey

Say what you may about the biotech chap­ter of the Hong Kong Stock Ex­change, but it has not stopped In­novent Bi­o­log­ics from reap­ing $421 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.